​

Harrow Health (HROW) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

HROW Stock Forecast

Harrow Health (HROW) stock forecast, based on 10 Wall Street analysts, predicts a 12-month average price target of $75.67, with a high of $94.00 and a low of $63.00. This represents a 90.60% increase from the last price of $39.70.

$10 $27 $44 $61 $78 $95 High: $94 Avg: $75.67 Low: $63 Last Closed Price: $39.7

HROW Stock Rating

Harrow Health stock's rating consensus is Buy, based on 10 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 10 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 10 0 10 Strong Sell Sell Hold Buy Strong Buy

HROW Price Target Upside V Benchmarks

TypeNameUpside
StockHarrow Health90.60%
SectorHealthcare Stocks 15.45%
IndustrySpecialty & Generic Drug Manufacturers Stocks22.61%

Price Target Trends

1M3M12M
# Anlaysts-27
Avg Price Target-$66.50$71.57
Last Closing Price$39.70$39.70$39.70
Upside/Downside-67.51%80.28%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 26-8---8
Mar, 26-7---7
Feb, 26-8---8
Jan, 26-8---8
Dec, 25-8---8
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 18, 2026Thomas ShraderBTIG$63.00$34.6881.66%58.69%
Mar 04, 2026Yi ChenH.C. Wainwright$70.00$39.6276.68%76.32%
Nov 11, 2025Cantor Fitzgerald$94.00$38.74142.64%136.78%
Sep 29, 2025Thomas FlatenLake Street$70.00$47.1048.62%76.32%
Sep 23, 2025Chase KnickerbockerCraig-Hallum$64.00$48.9330.80%61.21%
Aug 13, 2025Yi ChenH.C. Wainwright$64.00$34.8383.75%61.21%
Jul 11, 2025Steve SeedhouseCantor Fitzgerald$76.00$34.93117.58%91.44%
Oct 18, 2024Sahil KazmiB.Riley Financial$73.00$56.4129.41%83.88%
Oct 04, 2024Brooks O'NeilLake Street$55.00$49.7510.55%38.54%
Aug 09, 2024Chase KnickerbockerCraig-Hallum$45.00$35.2527.66%13.35%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 18, 2026NomuraNeutraldowngrade
Mar 04, 2026H.C. WainwrightBuyBuyhold
Mar 03, 2026William BlairOutperformOutperformhold
Nov 11, 2025Cantor FitzgeraldOverweightOverweighthold
Oct 01, 2025B. RileyBuyBuyhold
Sep 29, 2025Lake StreetBuyBuyhold
Sep 23, 2025Craig-HallumBuyBuyhold
Aug 14, 2025BTIGBuyBuyhold
Aug 13, 2025H.C. WainwrightBuyBuyhold
Jul 11, 2025Cantor FitzgeraldOverweightinitialise

Financial Forecast

EPS Forecast

$-1 $0 $1 $2 $3 $4 $5 $6 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-0.69$-0.51$-0.75$-0.49$-0.14--
Avg Forecast$-0.48$-0.67$-0.52$-0.64$0.57$2.29$5.28
High Forecast$-0.47$-0.66$-0.50$-0.62$0.79$3.07$5.58
Low Forecast$-0.50$-0.70$-0.55$-0.67$0.33$1.51$5.15
Surprise %43.75%-23.88%44.23%-23.44%-124.56%--

Revenue Forecast

$50M $190M $330M $470M $610M $750M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$72.48M$88.59M$130.19M$199.61M$272.30M--
Avg Forecast$71.64M$89.54M$131.69M$191.85M$283.47M$427.48M$704.66M
High Forecast$73.28M$92.57M$137.39M$200.16M$295.75M$446.00M$735.18M
Low Forecast$70.00M$88.14M$129.12M$188.11M$277.94M$419.13M$690.90M
Surprise %1.16%-1.06%-1.13%4.05%-3.94%--

Net Income Forecast

$-50M $0 $50M $100M $150M $200M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-18.01M$-14.09M$-24.41M$-17.48M$-5.14M--
Avg Forecast$-15.76M$-21.85M$-17.11M$-21.03M$21.49M$91.07M$174.88M
High Forecast$-15.29M$-21.41M$-16.42M$-20.19M$25.70M$100.13M$181.91M
Low Forecast$-16.23M$-22.82M$-17.80M$-21.88M$10.90M$49.25M$167.84M
Surprise %14.22%-35.54%42.65%-16.88%-123.91%--

HROW Forecast FAQ

Is Harrow Health stock a buy?

Harrow Health stock has a consensus rating of Buy, based on 10 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 10 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Harrow Health is a favorable investment for most analysts.

What is Harrow Health's price target?

Harrow Health's price target, set by 10 Wall Street analysts, averages $75.67 over the next 12 months. The price target range spans from $63 at the low end to $94 at the high end, suggesting a potential 90.60% change from the previous closing price of $39.7.

How does Harrow Health stock forecast compare to its benchmarks?

Harrow Health's stock forecast shows a 90.60% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the specialty & generic drug manufacturers stocks industry (22.61%).

What is the breakdown of analyst ratings for Harrow Health over the past three months?

  • April 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Harrow Health’s EPS forecast?

Harrow Health's average annual EPS forecast for its fiscal year ending in December 2026 is $2.29, marking a -1735.71% decrease from the reported $-0.14 in 2025. Estimates for the following years are.

What is Harrow Health’s revenue forecast?

Harrow Health's average annual revenue forecast for its fiscal year ending in December 2026 is $427.48M, reflecting a 56.99% increase from the reported $272.3M in 2025. The forecast for.

What is Harrow Health’s net income forecast?

Harrow Health's net income forecast for the fiscal year ending in December 2026 stands at $91.07M, representing a -1872.13% decrease from the reported $-5.139M in 2025. Projections indicate .